職務概況
月薪NT$ 70,000+
台北市內湖區
條件要求
語文條件
英文
聽/精通、說/精通、讀/精通、寫/精通
工作經歷
不拘
職務描述
The Foundation Cell Therapy Biology of Cell Therapy is seeking a highly motivated Senior Research Investigator to study on enhancing immune cell property and development of novel cell therapy. The position will involve close collaboration with other research groups, such as genetic editing and iPSC differentiation groups. Deliver new strategies to enhance cell function, particular for NK cells, for immune cell therapy and design and execute a serial immunological and biological experiments to approve them are core expectations of this position.
This position offers an opportunity to make your work have directly impacts patients, and to work in an environment with scientific innovation and inclusivity.
Qualifications
• PhD, MD, or equivalent in Immunology, Cancer Biology, Cell Biology, or related discipline. +4 years' experience in immune-oncology drug discovery or cell therapy would be an advantage.
• Proven record of research efforts in Immunology, Cancer Immunology, Cell therapy or related fields is a must. Experience in NK cell biology, iPSC, gene editing would be a plus.
• Strong knowledge and experience in immunology, molecular biology and cell biology. Post experience in flow cytometry, cell sorting, and cell toxicity assay would be a plus.
• Experience in working across teams and fostering productive research collaborations.
• Excellent communication and presentation skills.
• The successful candidate should have the ability for independent thinking, troubleshooting, excellent communication, and teamwork skills.
• Self-motivator, passionate, hands-on, disciplined and proactive person with great team-work spirit
學歷要求
博士以上
科系要求
自然科學學科類、醫藥衛生學科類、農林漁牧學科類
上班時段
週末輪班補休
休假制度
依公司規定
工作技能
Laboratory Equipment Operation
New Drug Research and Experiment Planning and Execution
Conducting Pharmacognosy and Pharmacy Research and Development
實驗室設備操作 新藥研發實驗規劃執行 進行生藥與藥學研究發展
職務類別
Biological Researcher
Biotechnology Research and Development Staff
台北市信義區
生化科技研發業
BeiGene is a global biotechnology company that is discovering and developing innovative oncology treatments that are more accessible and affordable to cancer patients worldwide. We have a commercial presence in more than 60 markets, with products treating various forms of cancer, and our broad and deep pipeline has the potential to address 80 percent of cancers by incidence.
We have grown rapidly since our founding in 2010 to more than 10,000 colleagues working on five continents, including more than 1,100 oncology researchers, one of the largest such teams in the industry. We have administrative offices in Basel, Beijing and Cambridge, U.S.
As we have grown, we have also evolved. In 2022, the company published its first Environmental, Social and Governance report and introduced “Change in the Cure,” a framework that provides a path for helping us shape a better world by advancing global health, improving access to medicines and ensuring quality in all our work. We have also introduced initiatives to improve work/life balance for our colleagues.
Today, BeiGene is a 【TOP 50 Pharmaceutical Company】 and a 【TOP 20 Oncology Company】 in 2022.
To learn more about BeiGene, please visit www.beigene.com or follow us on LinkedIn at @BeiGene
